SEC 13F Intelligence

D.a. Davidson & Co. / AMGN

D.a. Davidson & Co.’s Amgen Inc Position

Does D.a. Davidson & Co. own Amgen Inc (AMGN)? Yes241.5K shares worth $85M (+0.52% of its 13F portfolio) as of Q1 2026, down from 248.2K shares the prior filed quarter.

Position Value
$85M
Q1 2026
Shares
241.5K
% of Portfolio
+0.52%
Quarters Held
30
currently held

Position History AMGN

Reported value by quarter
Q4 ’18: $21MQ4 ’18Q1 ’19: $23MQ2 ’19: $21MQ3 ’19: $24MQ4 ’19: $31MQ4 ’19Q1 ’20: $29MQ2 ’20: $25MQ3 ’20: $28MQ4 ’20: $27MQ4 ’20Q1 ’21: $41MQ2 ’21: $43MQ3 ’21: $39MQ4 ’21: $40MQ4 ’21Q1 ’22: $48MQ2 ’22: $49MQ3 ’22: $44MQ4 ’22: $51MQ4 ’22Q1 ’23: $49MQ2 ’23: $46MQ3 ’23: $56MQ4 ’23: $61MQ4 ’23Q1 ’24: $61MQ2 ’24: $66MQ3 ’24: $70MQ4 ’24: $58MQ4 ’24Q1 ’25: $72MQ2 ’25: $66MQ3 ’25: $69MQ4 ’25: $81MQ4 ’25Q1 ’26: $85Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026241.5K$85M+0.52%
Q4 2025248.2K$81M+0.50%
Q3 2025243.1K$69M+0.44%
Q2 2025236.8K$66M+0.47%
Q1 2025232.4K$72M+0.58%
Q4 2024224.2K$58M+0.48%
Q3 2024217.7K$70M+0.58%
Q2 2024212.7K$66M+0.59%
Q1 2024214.4K$61M+0.55%
Q4 2023210.7K$61M+0.60%
Q3 2023209.5K$56M+0.61%
Q2 2023205.5K$46M+0.48%
Q1 2023202.5K$49M+0.55%
Q4 2022194.3K$51M+0.60%
Q3 2022197.4K$44M+0.58%
Q2 2022200.9K$49M+0.61%
Q1 2022199.3K$48M+0.53%
Q4 2021177.1K$40M+0.42%
Q3 2021181.9K$39M+0.45%
Q2 2021178.2K$43M+0.51%
Q1 2021165.4K$41M+0.53%
Q4 2020115.4K$27M+0.41%
Q3 2020110.7K$28M+0.49%
Q2 2020107.6K$25M+0.47%
Q1 2020144.4K$29M+0.57%
Q4 2019129.3K$31M+0.50%
Q3 2019126.5K$24M+0.44%
Q2 2019115.9K$21M+0.40%
Q1 2019122.5K$23M+0.40%
Q4 2018107.5K$21M+0.41%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See D.a. Davidson & Co.’s full portfolio or all institutional holders of AMGN.